This report aims to provide a comprehensive presentation of the global market for Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs. This report contains market size and forecasts of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs in global, including the following market information:
Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Agonist Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs include Roche, Regeneron Pharmaceuticals, Bayer, Santen Oy, Kanghong Pharmaceuticals, Novartis, Eli Lilly and Company, TRACON Pharmaceuticals and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Segment Percentages, by Type, 2022 (%)
Agonist
Allosteric Modulator
Kinase Inhibitor
Monoclonal Antibody
Others
Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Regeneron Pharmaceuticals
Bayer
Santen Oy
Kanghong Pharmaceuticals
Novartis
Eli Lilly and Company
TRACON Pharmaceuticals
Pfizer
GSK
BIOCAD
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs, market overview.
Chapter 2: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size in revenue.
Chapter 3: Detailed analysis of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Overall Market Size
2.1 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size: 2022 VS 2032
2.2 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players in Global Market
3.2 Top Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies Ranked by Revenue
3.3 Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size Markets, 2022 & 2032
4.1.2 Agonist
4.1.3 Allosteric Modulator
4.1.4 Kinase Inhibitor
4.1.5 Monoclonal Antibody
4.1.6 Others
4.2 By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2024-2032
4.2.3 By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2024-2032
5.2.3 By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2022 & 2032
6.2 By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2024-2032
6.2.3 By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2018-2032
6.3.2 US Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.3.3 Canada Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.3.4 Mexico Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2018-2032
6.4.2 Germany Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.4.3 France Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.4.4 U.K. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.4.5 Italy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.4.6 Russia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.4.8 Benelux Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2018-2032
6.5.2 China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.5.3 Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.5.4 South Korea Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.5.6 India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2018-2032
6.6.2 Brazil Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.6.3 Argentina Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2018-2032
6.7.2 Turkey Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.7.3 Israel Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
6.7.5 UAE Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size, 2018-2032
7 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
7.1.4 Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Regeneron Pharmaceuticals
7.2.1 Regeneron Pharmaceuticals Company Summary
7.2.2 Regeneron Pharmaceuticals Business Overview
7.2.3 Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
7.2.4 Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2018-2023)
7.2.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
7.3.4 Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Santen Oy
7.4.1 Santen Oy Company Summary
7.4.2 Santen Oy Business Overview
7.4.3 Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
7.4.4 Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2018-2023)
7.4.5 Santen Oy Key News & Latest Developments
7.5 Kanghong Pharmaceuticals
7.5.1 Kanghong Pharmaceuticals Company Summary
7.5.2 Kanghong Pharmaceuticals Business Overview
7.5.3 Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
7.5.4 Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2018-2023)
7.5.5 Kanghong Pharmaceuticals Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
7.6.4 Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Company Summary
7.7.2 Eli Lilly and Company Business Overview
7.7.3 Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
7.7.4 Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2018-2023)
7.7.5 Eli Lilly and Company Key News & Latest Developments
7.8 TRACON Pharmaceuticals
7.8.1 TRACON Pharmaceuticals Company Summary
7.8.2 TRACON Pharmaceuticals Business Overview
7.8.3 TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
7.8.4 TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2018-2023)
7.8.5 TRACON Pharmaceuticals Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
7.9.4 Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 GSK
7.10.1 GSK Company Summary
7.10.2 GSK Business Overview
7.10.3 GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
7.10.4 GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2018-2023)
7.10.5 GSK Key News & Latest Developments
7.11 BIOCAD
7.11.1 BIOCAD Company Summary
7.11.2 BIOCAD Business Overview
7.11.3 BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Major Product Offerings
7.11.4 BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global Market (2018-2023)
7.11.5 BIOCAD Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Drivers in Global Market
Table 3. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs in Global Market
Table 5. Top Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Type
Table 9. List of Global Tier 1 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2024-2032
Table 30. Roche Company Summary
Table 31. Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 32. Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Regeneron Pharmaceuticals Company Summary
Table 35. Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 36. Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Regeneron Pharmaceuticals Key News & Latest Developments
Table 38. Bayer Company Summary
Table 39. Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 40. Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Bayer Key News & Latest Developments
Table 42. Santen Oy Company Summary
Table 43. Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 44. Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Santen Oy Key News & Latest Developments
Table 46. Kanghong Pharmaceuticals Company Summary
Table 47. Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 48. Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Kanghong Pharmaceuticals Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 52. Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Eli Lilly and Company Company Summary
Table 55. Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 56. Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Eli Lilly and Company Key News & Latest Developments
Table 58. TRACON Pharmaceuticals Company Summary
Table 59. TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 60. TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. TRACON Pharmaceuticals Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 64. Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. GSK Company Summary
Table 67. GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 68. GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. GSK Key News & Latest Developments
Table 70. BIOCAD Company Summary
Table 71. BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Offerings
Table 72. BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. BIOCAD Key News & Latest Developments
List of Figures
Figure 1. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Segment by Type in 2022
Figure 2. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Segment by Application in 2022
Figure 3. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in 2022
Figure 8. By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
Figure 16. US Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
Figure 28. China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
